Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hú, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,994

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,592

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

Vincent, M. J., Bergeron, É., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,831

Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture

de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J. H., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 731

Whipple's Disease

Fenollar, F., Puéchal, X., & Raoult, D. (2007) · New England Journal of Medicine · doi:10.1056/nejmra062477 · Cited by 651

In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine

Keyaerts, E., Vijgen, L., Maes, P., Neyts, J. H., & Ranst, M. A. V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.085 · Cited by 644

New insights into the antiviral effects of chloroquine

Savarino, A., Trani, L. D., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570

Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases

Al‐Bari, M. A. A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv018 · Cited by 477

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

Colson, P., Rolain, J., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105923 · Cited by 471

Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century

Rolain, J., Colson, P., & Raoult, D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.015 · Cited by 408

Risk Factors of Fatal Outcome in Patients With COVID-19 Pneumonia

Cellina, M. I., Gibelli, D. M., Pittino, C. V., Toluian, T., Marino, P., & Oliva, G. (2020) · Disaster Medicine and Public Health Preparedness · doi:10.1017/dmp.2020.346 · Cited by 14

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine

Babayeva, M., & Loewy, Z. G. (2020) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s275964 · Cited by 14

Impact of repurposed drugs on the symptomatic COVID-19 patients

Hussain, I., Hussain, A., Alajmi, M. F., Rehman, M. T., & Amir, S. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.11.009 · Cited by 15

Current Trends in Analytical Methods for the Determination of Hydroxychloroquine and Its Application as Treatment for COVID‐19

Mhammedi, M. A. E., Saqrane, S., Lahrich, S., Laghrib, F., Bouabi, Y. E., Farahi, A., & Bakasse, M. (2020) · ChemistrySelect · doi:10.1002/slct.202003361 · Cited by 14

Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission

Yamamoto, K., Suzuki, M., Yamada, G., Sudo, T., Nomoto, H., Kinoshita, N., Nakamura, K., Tsujimoto, Y., Kusaba, Y., Morita, C., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.12.079 · Cited by 14

Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice

Choi, B., Koo, Y., Kim, T. Y., Chung, W. Y., Jung, Y. J., Park, J. E., Lim, H., Park, B., & Yoon, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-86321-z · Cited by 14

Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial

Solanich, X., Antolí, A., Rocamora-Blanch, G., Zamora, N. P., Fanlo‐Maresma, M., Iriarte, A., Mitjavila, F., Capdevila, O., Riera‐Mestre, A., Bas, J., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.691712 · Cited by 14

Clinical Symptoms and Types of Samples Are Critical Factors for the Molecular Diagnosis of Symptomatic COVID-19 Patients: A Systematic Literature Review

Zandi, M., Farahani, A. S., Zakeri, A., Rezayat, S. A., Mohammadi, R., Das, U., Dimmock, J. R., Afzali, S., Nakhaei, M. A., Doroudi, A., et al. (2021) · International Journal of Microbiology · doi:10.1155/2021/5528786 · Cited by 14

In silico screening, SAR and kinetic studies of naturally occurring flavonoids against SARS CoV-2 main protease

Imran, M., Iqbal, S., Hussain, A., Uddin, J., Shahzad, M., Khaliq, T., Ahmed, A., Mushtaq, L., Kashif, M. A., & Mahmood, K. (2021) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2021.103473 · Cited by 14

Potential of Quinine Sulfate for COVID-19 Treatment and Its Safety Profile: Review

Latarissa, I. R., Barliana, M. I., Meiliana, A., & Lestari, K. (2021) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s331660 · Cited by 17

Electrocatalytic Determination of Hydroxychloroquine Using Sodium Dodecyl Sulphate Modified Carbon Nanotube Paste Electrode

Pushpanjali, P. A., Manjunatha, J. G., Hareesha, N., Girish, T., Al‐Kahtani, A. A., TIGHEZZA, A. M., & Ataollahi, N. (2022) · Topics in Catalysis · doi:10.1007/s11244-022-01568-8 · Cited by 14

Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants

Delandre, O., Gendrot, M., Jardot, P., Bideau, M. L., Boxberger, M., Boschi, C., Fonta, I., Mosnier, J., Hutter, S., Levasseur, A., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15040445 · Cited by 14

Cardiovascular Implications and Therapeutic Considerations in COVID-19 Infection

Judson, G. L., Kelemen, B. W., Njoroge, J. N., & Mahadevan, V. S. (2020) · Cardiology and Therapy · doi:10.1007/s40119-020-00184-5 · Cited by 14

Chloroquine and COVID-19: A Light at the End of the Tunnel, or is it Another Train?

Aljofan, M., & Gaipov, A. (2020) · Electronic Journal of General Medicine · doi:10.29333/ejgm/7863 · Cited by 13

In Silico Identification of Clinically Approved Medicines Against the main Protease of Sars-Cov-2 – A Causative Agent of Covid-19

Mamidala, E., Davella, R., Gurrapu, S., & Shivakrishna, P. (2021) · International Journal of Life Science and Pharma Research · doi:10.22376/ijpbs/lpr.2021.11.1.l107-122 · Cited by 13

Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience

Raza, H., Wahid, B., Rubi, G., & Gulzar, A. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104374 · Cited by 13

Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019

Schluenz, L., Ramos-Otero, G. P., & Nawarskas, J. J. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000329 · Cited by 12

Possible Retinal Impairment Secondary to Ritonavir Use in SARS-CoV-2 Patients: A Narrative Systematic Review

Cozzupoli, G. M., Savastano, M. C., Falsini, B., Savastano, A., & Rizzo, S. (2020) · Journal of Ophthalmology · doi:10.1155/2020/5350494 · Cited by 13

Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study

Almazrou, S. H., Almalki, Z. S., Alanazi, A. S., Alqahtani, A., & Alghamd, S. M. (2020) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2020.09.019 · Cited by 13

Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease

Cafiero, C., Re, A., Micera, A., Palmirotta, R., Monaco, D., Romano, F., Fabrizio, C., Francia, R. D., Cacciamani, A., Surico, P. L., et al. (2020) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s270069 · Cited by 13

Analysis of the US FDA adverse event reporting system to identify adverse cardiac events associated with hydroxychloroquine in older adults

Nishtala, P. S., Gill, S., & Chyou, T. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5155 · Cited by 13

Cardiovascular Complications of COVID-19 and Associated Concerns: A Review.

Yu, W.-L., Toh, H. S., Liao, C.-T., & Chang, W. (2021) · Europe PMC (PubMed Central) · doi:10.6515/acs.202101_37(1).20200913a · Cited by 13

Repurposed drug against COVID-19: nanomedicine as an approach for finding new hope in old medicines

Ahmad, M. Z., Ahmad, J., Aslam, M., Khan, M. A., Alasmary, M. Y., & Abdel‐Wahab, B. A. (2021) · Nano Express · doi:10.1088/2632-959x/abffed · Cited by 13

Testing the feasibility of operationalizing a prospective, randomized trial with remote cardiac safety EKG monitoring during a pandemic

Liu, H. H., Ezekowitz, M. D., Columbo, M., Khan, O., Martin, J. L., Spahr, J., Yaron, D., Cushinotto, L., & Kapelusznik, L. (2021) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-021-00989-x · Cited by 13

Overview of Hydroxychloroquine and Remdesivir on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)

Kabi, A. K., Pal, M., Gujjarappa, R., Malakar, C. C., & Roy, M. (2022) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.4541 · Cited by 13

Enantiomers of Chloroquine and Hydroxychloroquine Exhibit Different Activities Against SARS-CoV-2 in vitro , Evidencing S -Hydroxychloroquine as a Potentially Superior Drug for COVID-19Preprint

Li, G., Sun, J., Huang, Y., Li, Y., Shi, Y., Li, Z., Li, X., Yang, F., Zhao, J., Luo, H., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.26.114033 · Cited by 13

A Novel RP-HPLC-DAD Method Development for Anti-Malarial and COVID-19 Hydroxy Chloroquine Sulfate Tablets and Profiling of In-Vitro Dissolution in Multimedia.Preprint

Dongala, T., Ettaboina, S. K., & Katari, N. K. (2020) · doi:10.21203/rs.3.pex-880/v2 · Cited by 13

Social Media Reveals Psychosocial Effects of the COVID-19 PandemicPreprint

Saha, K., Torous, J. B., Caine, E. D., & Choudhury, M. D. (2020) · medRxiv · doi:10.1101/2020.08.07.20170548 · Cited by 13

Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns

Jankowska, E. A., Sierpiński, R., Tkaczyszyn, M., Drozd, M., Szachniewicz, J., Duda-Sikuła, M., Knysz, B., Simon, K. A., Szenborn, L., & Ponikowski, P. P. (2020) · Kardiologia Polska · doi:10.33963/kp.15511 · Cited by 12

Efficacy and Safety of Hydroxychloroquine for Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis

Hernández, A. V., Phan, M. T., Rocco, J., Pasupuleti, V., Barboza, J. J., Piscoya, A., Roman, Y. M., & White, C. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112503 · Cited by 12

Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)—protocol of randomised controlled trial AZIQUINE-ICU

Duška, F., Waldauf, P., Halačová, M., Zvoníček, V., Bala, J., Balík, M., Beneš, J., Klementová, O., Kozáková, I., Kubricht, V., et al. (2020) · Trials · doi:10.1186/s13063-020-04566-x · Cited by 13

Saudi Society of Maternal-Fetal Medicine guidance on pregnancy and coronavirus disease 2019

Faden, Y. A., Ghilan, N. A., Alawami, S. H., Alsulmi, E. S., Al-Sum, H., Katib, Y., Sabr, Y., Tahir, F., & Bondagji, N. (2020) · Saudi Medical Journal · doi:10.15537/smj.2020.8.25222 · Cited by 12

Chitosan-drug encapsulation as a potential candidate for COVID-19 drug delivery systems: A review

Ejeromedoghene, O., Oderinde, O., Egejuru, G., & Adewuyi, S. (2020) · Journal of the Turkish Chemical Society Section A Chemistry · doi:10.18596/jotcsa.773780 · Cited by 12

Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: Single center cohort study of 685 patients

Buzón, L., Montero-Baladía, M., Pedro, D.-L., Iglesias-Posadilla, D., Astigarraga, I., Galacho-Harriero, A. M., Julián, E. I., López-Veloso, M., Noelia, D. L. T.-F., César, B.-B. J., et al. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100086 · Cited by 12

Co-Infection with COVID-19 and Malaria in a Young Man

Eid, M. M. (2021) · Dubai Medical Journal · doi:10.1159/000514254 · Cited by 12

Chemo-Preventive Effect of Vegetables and Fruits Consumption on the COVID-19 Pandemic.

Yedjou, C. G., Aló, R., Liu, J., Enow, J., Ngnepiepa, P., Long, R., Latinwo, L. M., & Tchounwou, P. B. (2021) · PubMed · Cited by 12

Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage

Wang, K., Wu, J., XinZHANG, Zeng, Q., Zhang, N., Huang, W., Tang, S., Wang, Y., Kong, W., Wang, Y., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105196 · Cited by 12

COVID-19: только научные факты

(2020) · Dalʹnevostočnyj medicinskij žurnal · doi:10.35177/1994-5191-2020-1-5-22 · Cited by 12

Negative Nasopharyngeal SARS-CoV-2 PCR Conversion in Response to Different Therapeutic Interventions

Alwafi, H. H., Shabrawishi, M., Naser, A. Y., Aldobyany, A., Qanash, S. A., & Touman, A. (2022) · Cureus · doi:10.7759/cureus.21442 · Cited by 12

Homeopathy as an Adjuvant to Standard Care in Moderate and Severe Cases of COVID-19: A Single-Blind, Randomized, Placebo-Controlled Study

Kaur, H., Kaushik, S., Singh, G., Kumar, A., Singh, S., Chatterjee, T., Ali, S. Z., Gautam, K., Parewa, M., Verma, N. K., et al. (2022) · Homeopathy · doi:10.1055/s-0042-1755365 · Cited by 12

Boron nitride nanocage as drug delivery systems for chloroquine, as an effective drug for treatment of coronavirus disease: A DFT study

Alharthy, K. M., Alsaffar, M. F., Althurwi, H. N., Albaqami, F. F., Abass, R. R., Alawi, A. M., Jalal, S. S., Tabassum, S., Zhang, H., & Wang, P. (2023) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2023.110482 · Cited by 12

Potential small‐molecule drugs as available weapons to fight novel coronavirus ( 2019‐nCoV ): A review

Rahimkhoei, V., Jabbari, N., Nourani, A., Sharifi, R., & Akbari, A. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3576 · Cited by 11

Dynamical characterization of antiviral effects in COVID-19

Abuin, P., Anderson, A., Ferramosca, A., Hernandez-Vargas, E. A., & González, A. H. (2021) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2021.05.001 · Cited by 12

A Review of the Progress of COVID-19 Vaccine Development

Ullah, S., Al-Sehemi, A. G., Klemeš, J. J., SAQIB, S., GONDAL, S. M. A., SAQIB, S., ARSHAD, A., Saqib, H., Mukhtar, A., IBRAHIM, M., et al. (2021) · Düzce Tıp Fakültesi Dergisi · doi:10.18678/dtfd.890089 · Cited by 12

Humidifier Use and Prone Positioning in a Patient with Severe COVID-19 Pneumonia and Endotracheal Tube Impaction Due to Highly Viscous Sputum

Sugimoto, R., Kenzaka, T., Fujikawa, M., Kawasaki, S., & Nishisaki, H. (2020) · Cureus · doi:10.7759/cureus.8626 · Cited by 12

Remdesivir use in patients with coronavirus COVID-19 disease: a systematic review and meta-analysis of the Chinese Lancet trial with the NIH trialPreprint

Alexander, P. E., Piticaru, J., Lewis, K. A., Aryal, K., Thomas, P., Szczeklik, W., Fronczek, J., Polok, K., Alhazzani, W. A., & Mammen, M. J. (2020) · medRxiv · doi:10.1101/2020.05.23.20110932 · Cited by 12

Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria

Aouissi, H. A., Ababsa, M., & Gaagai, A. (2021) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-021-00550-w · Cited by 11

Care of immunocompromised patients with head and neck cancer during the COVID ‐19 pandemic: Two challenging and informative clinical cases

Civantos, A. M., Carey, R. M., Lichtenstein, G. R., Lukens, J. N., Cohen, R. B., & Rassekh, C. H. (2020) · Head & Neck · doi:10.1002/hed.26165 · Cited by 11

Optimizing the Use of Hydroxychloroquine in the Management of COVID-19 Given Its Pharmacological Profile

Ali, A. S., Abdel-Rahman, M. S., Almalikil, R. S., Mohamed, A. S., Alfaifi, K. A., Fadil, A. E., El‐Shitany, N. A., & Alkreathy, H. M. (2020) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2020/v32i830468 · Cited by 11

COVID-19 and the burning issue of drug interaction: never forget the ECG

Sciaccaluga, C., Cameli, M., Menci, D., Mandoli, G. E., Sisti, N., Cameli, P., Franchi, F., Mondillo, S., & Valente, S. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138093 · Cited by 11

KEBIJAKAN HUKUM PIDANA SEBAGAI UPAYA PENANGGULANGAN KEDARURATAN COVID-19

Firdaus, A., & Pakpahan, R. H. (2020) · Majalah Hukum Nasional · doi:10.33331/mhn.v50i2.61 · Cited by 11

The Rise and Fall of Hydroxychloroquine and Chloroquine in COVID-19

Aljadeed, R. (2021) · Journal of Pharmacy Practice · doi:10.1177/0897190021997399 · Cited by 12

An approach to rapid distributed manufacturing of broad spectrum anti-viral griffithsin using cell-free systems to mitigate pandemics

Borhani, S., Levine, M. Z., Krumpe, L. R. H., Wilson, J. A., Henrich, C. J., O’Keefe, B. R., Lo, D. C., Sittampalam, G. S., Godfrey, A. G., Lunsford, R. D., et al. (2023) · New Biotechnology · doi:10.1016/j.nbt.2023.04.003 · Cited by 12

Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed

Hassani, R. T. J., & Bennis, A. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.05.005 · Cited by 11

Drug-drug and drug-solvent interaction studies of Chloroquine phosphate, Acefylline piperazine and Gentamicin sulfate in polymeric systems

Masood, S., Rehman, W., Begum, S., Khan, Z., & Gulnar, L. (2020) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2020.05.030 · Cited by 11

Current Options in the Treatment of COVID-19: A Review

Teimury, A., & Khaledi, E. M. (2020) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s265030 · Cited by 12

YouTube as a source of information on chloroquine and hydroxychloroquine during the COVID-19 pandemic

Ramos, T. B., Bokehi, L. C., Bokehi, R. C., Pinheiro, T. D. S., de Oliveira, E. B., Torres, R. D. S. G., Bokehi, J. R., Calil-Eliás, S., & de Castilho, S. R. (2020) · Journal of Science Communication · doi:10.22323/2.19070206 · Cited by 10

In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV

Udofia, I. A., Gbayo, K. O., Oloba‐Whenu, O. A., Ogunbayo, T. B., & Isanbor, C. (2021) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-021-00299-2 · Cited by 11

An update on emerging therapeutics to combat COVID‐19

Shah, N. N., Nabi, S. U., Rather, M. A., Kalwar, Q., Ali, S. I., Sheikh, W. M., Ganai, A., & Bashir, S. M. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13600 · Cited by 10

Zinc augments the antiviral potential of HCQ/CQ and ivermectin to reduce the risks of more serious outcomes from COVID-19 infection

Boretti, A. A. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.126954 · Cited by 11

A Mechanism of Action for Hydroxychloroquine and Azithromycin to Inhibit Coronavirus Disease COVID-19Preprint

Schaper, C. D. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12148914.v1 · Cited by 11

SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis

Dousa, K. M., Malavade, S. S., Furin, J. J., Gripshover, B., Hatszegi, M., Hojat, L. S., Saade, E. A., & Salata, R. A. (2020) · IDCases · doi:10.1016/j.idcr.2020.e00778 · Cited by 10

Genomic Variations of SARS-CoV-2 and Effect of Various Factors on COVID-19

Rani, A., Arya, R., & Sharma, P. (2020) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2020.sp57 · Cited by 10

Molecular Modeling of Viral Type I Fusion Proteins: Inhibitors of Influenza Virus Hemagglutinin and the Spike Protein of Coronavirus

Borisevich, S. S., Zarubaev, V. V., Щербаков, Д. Н., Yarovaya, О. I., & Salakhutdinov, N. F. (2023) · Viruses · doi:10.3390/v15040902 · Cited by 10

Combined treatment of tocilizumab and chloroquine on severe COVID-19: a case report

Xu, C., Shu-cheng, L., Ye, X., Cao, M. Y., Xu, G., Yu, Q., Qian, J. X., & Zeng, G. (2020) · QJM · doi:10.1093/qjmed/hcaa153 · Cited by 10

Adverse Cardiac Events Related to Hydroxychloroquine Prophylaxis and Treatment of COVID-19

Zengin, R., Sarıkaya, Z. T., Karadag, N., Çuhadaroğlu, Ç., Ergönül, Ö., & Kocagöz, S. (2020) · Infectious Diseases and Clinical Microbiology · doi:10.36519/idcm.2020.0012 · Cited by 10

Quinine Esters with 1,2-Azole, Pyridine and Adamantane Fragments

Mukusheva, G. K., Zhasymbekova, A. R., Сейдахметова, Р. Б., Нуркенов, О. А., Akishina, E. A., Petkevich, S. K., Dikusar, E. A., & Potkin, V. I. (2022) · Molecules · doi:10.3390/molecules27113476 · Cited by 11

In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing

Mohamed, E. A. R., Abdel-Rahman, I. M., Zaki, M. E. A., Al-Khdhairawi, A. A. Q., Abdelhamid, M. M. H., Alqaisi, A. M., Rahim, L. B. A., Abu-Hussein, B., El‐Sheikh, A. A. K., Abdelwahab, S. F., et al. (2023) · Journal of Molecular Modeling · doi:10.1007/s00894-023-05457-z · Cited by 10

Facts and Myths: Efficacies of Repurposing Chloroquine and Hydroxychloroquine for the Treatment of COVID-19

Al‐Bari, M. A. A. (2020) · Current Drug Targets · doi:10.2174/1389450121666200617133142 · Cited by 9

Repurposing current therapeutic regimens against SARS-CoV-2 (Review)

Konstantinidou, S. M., & Papanastasiou, I. P. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8905 · Cited by 10

Coronavirus Treatments: What Drugs Might Work Against COVID-19?

Bourhia, M., Amrati, F. E., Ullah, R., Alqahtani, A. S., Bousta, D., Ibenmoussa, S., & Khlil, N. (2020) · Natural Product Communications · doi:10.1177/1934578x20945442 · Cited by 10

Mechanisms Underlying the Effects of Chloroquine on Red Blood Cells Metabolism

Russo, A., Patanè, G. T., Putaggio, S., Lombardo, G. E., Ficarra, S., Barreca, D., Giunta, E., Tellone, E., & Laganà, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126424 · Cited by 9

Therapeutic approaches for COVID 19: Challenges and successes

Harfouch, R., Alshaikh, S., Alshimaly, M., Assaad, A., Ahmad, J., Zoughaibi, H., Hammadi, M., & Elshimali, Y. (2021) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.20270 · Cited by 9

Sustainable Post Covid19 Lockdown Strategy Through Evidence-Based Policy

Boretti, A. A. (2020) · Integrative Journal of Medical Sciences · doi:10.15342/ijms.7.172 · Cited by 9

Effects of Nanoparticles on Viral Infection — A Review

Chowdhury, M. A., Hossain, N., Kashem, M. A., Shahid, M. A., & Alam, A. (2020) · NANO · doi:10.1142/s1793292020300030 · Cited by 9

Antivirals virtual screening to SARS-CoV-2 non-structural proteins

Nunes, V. S., Paschoal, D. F. D. S., Costa, L. A. S., & Santos, H. F. D. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1921033 · Cited by 10

Current challenges in identification of clinical characteristics and detection of COVID-19: A comprehensive review

More, N., Ranglani, D., Kharche, S., Choppadandi, M., Ghosh, S. K., Vaidya, S., & Kapusetti, G. (2021) · Measurement Sensors · doi:10.1016/j.measen.2021.100052 · Cited by 9

Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach

Das, A., Roy, S., Swarnakar, S., & Chatterjee, N. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108804 · Cited by 11

Computational study for identifying promising therapeutic agents of hydroxychloroquine analogues against SARS‐CoV‐2

Prasanth, D., Murahari, M., Chandramohan, V., Guntupalli, C., & Rao, A. L. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1965027 · Cited by 9

MD simulation and MM/PBSA identifies phytochemicals as bifunctional inhibitors of SARS-CoV-2

Sharma, M., Mahto, J. K., Dhaka, P., Neetu, N., Tomar, S., & Kumar, P. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1969285 · Cited by 9

Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study

Rouamba, T., Barry, H., Ouédraogo, E., Tahita, M. C., Yaméogo, N. V., Poda, A., Diendéré, É. A., Ouédraogo, A., Valéa, I., Koné, A., et al. (2021) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s330813 · Cited by 9

Acute respiratory syndrome-2 (SARS-CoV-2): A solution of hydrogen peroxide and sodium bicarbonate as an expectorant for recanalization of the respiratory tract and blood oxygenation in respiratory obstruction (review)

Ураков, А. Л., & Shabanov, P. D. (2021) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf194383-393 · Cited by 9

SARS-CoV-2 in the Environment: Its Transmission, Mitigation, and Prospective Strategies of Safety and Sustainability

Sami, N., Ahmad, R., Afzal, B., Naaz, H., & Fatma, T. (2022) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/s44169-022-00009-7 · Cited by 9

Basic Critical Care for Management of COVID-19 Patients: Position Paper of the Indian Society of Critical Care Medicine, Part II

Ramasubban, S., Juneja, D., Dixit, S., Reddy, P. K., Gopal, P. B. N., Savio, R. D., & Singh, M. K. (2020) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23593 · Cited by 9

Plant Cell and Callus Cultures as an Alternative Source of Bioactive Compounds with Therapeutic Potential against Coronavirus Disease (COVID-19)

Abdulhafiz, F., Mohammed, A., Khalivulla, S. I., Korivi, M., & Razab, M. K. A. A. (2020) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/596/1/012099 · Cited by 9

Climatic influence on the magnitude of COVID-19 outbreak: a stochastic model-based global analysisPreprint

Pramanik, M., Chowdhury, K., Rana, M. J., Bisht, P., Pal, R., Szabo, S., Pal, I., Behera, B., Liang, Q., Padmadas, S. S., et al. (2020) · medRxiv · doi:10.1101/2020.06.02.20120501 · Cited by 9

As pílulas do Messias: salvação, negação e política de morte em tempos de pandemia

Silva, R. D. F. D. C., & Gonçalves, L. A. P. (2020) · Physis Revista de Saúde Coletiva · doi:10.1590/s0103-73312020300208 · Cited by 9

SARS-CoV-2 and the Eye: The Pandora's Box of Ocular Immunology

Neri, P., & Pichi, F. (2021) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2021.0058 · Cited by 9

Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity?

Lasheras, I., & Santabárbara, J. (2020) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2020.04.002 · Cited by 8

Adverse drug reaction profile of prophylactic hydroxychloroquine for COVID-19 among doctors

Kulkarni, R., Kinikar, A. A., & Jadhav, T. (2020) · Medical Journal of Dr D Y Patil Vidyapeeth · doi:10.4103/mjdrdypu.mjdrdypu_220_20 · Cited by 8

Covid-19’un Klinik Yönetimi ve Hemşirelik

DEMİRAĞ, H., & Hıntıstan, S. (2020) · Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi · doi:10.37989/gumussagbil.727393 · Cited by 8

Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease.

Oso, B. J., Olaoye, I. F., & Omeike, S. O. (2021) · PubMed Central · doi:10.22092/ari.2020.351202.1517 · Cited by 8

CAUSES OF DEATH AMONG MUSCOVITES BEFORE AND DURING THE COVID-19 PANDEMIC

Sabgayda, T. P., Ivanova, A., Rudnev, S. G., & Semyonova, V. G. (2020) · Social Aspects of Population Health · doi:10.21045/2071-5021-2020-66-4-1 · Cited by 10

No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19

Sands, K., Wenzel, R. P., McLean, L. E., Korwek, K. M., Roach, J. D., Miller, K. M., Poland, R. E., Burgess, L. H., Jackson, E. S., & Perlin, J. B. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.12.060 · Cited by 8

Identification of Mpro inhibitors of SARS-CoV-2 using structure based computational drug repurposing

Nath, V., Rohini, A., & Kumar, V. (2021) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2021.102178 · Cited by 8

Can Anti-Parasitic Drugs Help Control COVID-19?

Panahi, Y., Dadkhah, M., Talei, S., Gharari, Z., Asghariazar, V., Abdolmaleki, A., Matin, S., & Molaei, S. (2022) · Future Virology · doi:10.2217/fvl-2021-0160 · Cited by 8

Insights into SARS-CoV-2: Medicinal Chemistry Approaches to Combat Its Structural and Functional Biology

Zhuo, L., Wang, M., Yang, J., Xu, H.-C., Huang, W., Shang, L., & Yang, G. (2021) · Topics in Current Chemistry · doi:10.1007/s41061-021-00335-9 · Cited by 8

Potential Phytochemicals as Efficient Protease Inhibitors of 2019-nCoVPreprint

Ranjan, A., Chauhan, A. P. S., Gurnani, M., & Jindal, T. (2020) · Preprints.org · doi:10.20944/preprints202004.0240.v1 · Cited by 8

Chloroquine drug and Graphene complex for treatment of COVID-19Preprint

Mohammadi, S., Esmailpour, M., & Mohammadi, M. (2020) · doi:10.21203/rs.3.rs-29418/v1 · Cited by 8

Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine

Latarissa, I. R., Khairinisa, M. A., Iftinan, G. N., Meiliana, A., Sormin, I. P., Barliana, M. I., & Lestari, K. (2025) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s493750 · Cited by 8

Can we use hydroxychloroquine to treat COVID-19 now?

Chen, J., Liu, D., Yin, L., Zhang, L., & Lu, H. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106173 · Cited by 1

Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine

Sahraei, Z., Shabani, M., Shokouhi, S., & Saffaei, A. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105945 · Cited by 234

Chloroquine and hydroxychloroquine as potential therapies against COVID-19

Yewange, S., Deshpande, R. R., Waghmare, N., Vidyasagar, G., Bavage, S. B., & Bavage, N. B. (2020) · Cited by 1

Chloroquine as a prophylactic agent against COVID-19?

Gendrot, M., Javelle, É., Clerc, A., Savini, H., & Pradines, B. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105980 · Cited by 44

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

Colson, P., Rolain, J., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105923 · Cited by 471